Eledon Pharmaceuticals (ELDN) Total Current Liabilities (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Total Current Liabilities of $13.5 million for Q1 2026, up 46.52% year-on-year from $9.2 million in Q1 2025, and down 26.64% on a QoQ basis from $18.3 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Total Current Liabilities data on file, last reported at $13.5 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 46.52% year-over-year to $13.5 million; the trailing twelve-month figure through Mar 2026 stood at $13.5 million (up 46.52% YoY), and the FY2025 full-year result was $18.3 million, up 58.45% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $13.5 million, down from $18.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $18.3 million in Q4 2025 and bottomed at $2.9 million in Q3 2023.
- The 5-year median for Total Current Liabilities is $6.3 million (2022), against an average of $8.2 million.
- The widest annual swing landed in 2023, when Total Current Liabilities plunged 53.84%; it then surged 330.8% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $6.5 million in 2022, then sank by 39.85% to $3.9 million in 2023, then jumped by 197.23% to $11.6 million in 2024, then jumped by 58.45% to $18.3 million in 2025, then retreated by 26.64% to $13.5 million in 2026.
- The last three Total Current Liabilities figures came in at $13.5 million (Q1 2026), $18.3 million (Q4 2025), and $14.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 13.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.46 Mn |
| Dec 31, 2025 | 18.34 Mn |
| Sep 30, 2025 | 14.30 Mn |
| Jun 30, 2025 | 13.72 Mn |
| Mar 31, 2025 | 9.19 Mn |
| Dec 31, 2024 | 11.58 Mn |
| Sep 30, 2024 | 12.49 Mn |
| Jun 30, 2024 | 6.03 Mn |
| Mar 31, 2024 | 4.25 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 2.90 Mn |
| Jun 30, 2023 | 4.90 Mn |
| Mar 31, 2023 | 5.48 Mn |
| Dec 31, 2022 | 6.48 Mn |
| Sep 30, 2022 | 6.28 Mn |
| Jun 30, 2022 | 3.28 Mn |
| Mar 31, 2022 | 2.96 Mn |
| Dec 31, 2021 | 4.40 Mn |
| Sep 30, 2021 | 4.05 Mn |
| Jun 30, 2021 | 2.68 Mn |
| Mar 31, 2021 | 4.21 Mn |
| Dec 31, 2020 | 2.48 Mn |
| Sep 30, 2020 | 6.13 Mn |
| Jun 30, 2020 | 1.10 Mn |
| Mar 31, 2020 | 1.88 Mn |
| Dec 31, 2019 | 1.32 Mn |
| Sep 30, 2019 | 1.66 Mn |
| Jun 30, 2019 | 1.95 Mn |
| Mar 31, 2019 | 3.24 Mn |
| Dec 31, 2018 | 2.53 Mn |
| Sep 30, 2017 | 2.31 Mn |
| Jun 30, 2017 | 3.16 Mn |
| Mar 31, 2017 | 2.42 Mn |
| Dec 31, 2016 | 3.90 Mn |
| Sep 30, 2016 | 6.34 Mn |
| Jun 30, 2016 | 7.82 Mn |
| Mar 31, 2016 | 6.18 Mn |
| Dec 31, 2015 | 6.16 Mn |
| Sep 30, 2015 | 5.66 Mn |
| Jun 30, 2015 | 4.65 Mn |
| Mar 31, 2015 | 5.75 Mn |
| Dec 31, 2014 | 4.24 Mn |
| Sep 30, 2014 | 5.37 Mn |
| Dec 31, 2013 | 2.21 Mn |